Greatmark Investment Partners, Inc. Abb Vie Inc. Transaction History

Greatmark Investment Partners, Inc.

$737 Million
Q3 2024

A detailed history of Greatmark Investment Partners, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Greatmark Investment Partners, Inc. holds 39,515 shares of ABBV stock, worth $7.08 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

39,515

Previous 39,705 0.48%

Holding current value

$7.08 Million

Previous $6.81 Million 14.58%

% of portfolio

1.06%

Previous 0.99%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$163.84 - $199.33 $31,129 - $37,872	-190 Reduced 0.48%	39,515 $7.8 Million
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $39,471 - $46,093	-255 Reduced 0.64%	39,705 $6.81 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $155,025 - $176,637	-970 Reduced 2.37%	39,960 $7.28 Million
Q4 2023 Feb 05, 2024	SELL	$137.6 - $154.97 $168,284 - $189,528	-1,223 Reduced 2.9%	40,930 $6.34 Million
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $20,038 - $23,197	-150 Reduced 0.35%	42,153 $6.28 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $321,336 - $399,882	-2,425 Reduced 5.42%	42,303 $5.7 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $255,959 - $294,775	-1,770 Reduced 3.81%	44,728 $7.13 Million
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $311,889 - $374,036	-2,255 Reduced 4.63%	46,498 $7.52 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $25,768 - $29,554	-192 Reduced 0.39%	48,753 $6.54 Million
Q2 2022 Jul 28, 2022	SELL	$137.62 - $174.96 $140,785 - $178,984	-1,023 Reduced 2.05%	48,945 $7.5 Million
Q1 2022 Apr 27, 2022	SELL	$131.98 - $163.75 $16,497 - $20,468	-125 Reduced 0.25%	49,968 $8.1 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $136,973 - $173,310	-1,275 Reduced 2.48%	50,093 $6.78 Million
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $147,364 - $167,280	-1,385 Reduced 2.63%	51,368 $5.54 Million
Q2 2021 Aug 23, 2021	SELL	$105.21 - $117.21 $44,714 - $49,814	-425 Reduced 0.8%	52,753 $5.94 Million
Q1 2021 May 04, 2021	SELL	$102.3 - $112.62 $224,548 - $247,200	-2,195 Reduced 3.96%	53,178 $5.76 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $67,209 - $90,739	-835 Reduced 1.49%	55,373 $5.93 Million
Q3 2020 Oct 28, 2020	SELL	$85.91 - $100.83 $105,239 - $123,516	-1,225 Reduced 2.13%	56,208 $4.92 Million
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $387,760 - $518,881	-5,285 Reduced 8.43%	57,433 $5.64 Million
Q1 2020 Apr 29, 2020	BUY	$64.5 - $97.79 $76,755 - $116,370	1,190 Added 1.93%	62,718 $4.78 Million
Q4 2019 Jan 31, 2020	BUY	$72.13 - $90.25 $204,127 - $255,407	2,830 Added 4.82%	61,528 $5.45 Million
Q3 2019 Oct 30, 2019	BUY	$62.98 - $75.72 $422,595 - $508,081	6,710 Added 12.91%	58,698 $4.45 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $1.53 Million - $1.96 Million	23,300 Added 81.22%	51,988 $3.78 Million
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $20,442 - $24,059	-265 Reduced 0.92%	28,688 $2.31 Million
Q4 2018 Feb 01, 2019	SELL	$77.85 - $96.01 $249,119 - $307,232	-3,200 Reduced 9.95%	28,953 $2.67 Million
Q3 2018 Oct 31, 2018	BUY	$88.91 - $98.84 $55,124 - $61,280	620 Added 1.97%	32,153 $3.04 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $67,167 - $89,943	-730 Reduced 2.26%	31,533 $2.99 Million
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $176,881 - $193,964	-1,975 Reduced 5.77%	32,263 $3.12 Million
Q3 2017 Nov 02, 2017	BUY	$69.85 - $89.22 $2.39 Million - $3.05 Million	34,238	34,238 $3.04 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greatmark Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greatmark Investment Partners, Inc. with notifications on news.

Account

Greatmark Investment Partners, Inc. Abb Vie Inc. Transaction History